Efficacy of celecoxib in treating symptoms of viral pharyngitis: A double-blind, randomized study of celecoxib versus diclofenac

This study compared the efficacy and safety of the cyclooxygenase-2 specific inhibitor celecoxib with the conventional non-steroidal anti-inflammatory drug diclofenac in the symptomatic treatment of viral pharyngitis. Adult patients from 27 study centers in Latin America were treated with oral doses...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2002

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/22385

Acceso en línea:

https://doi.org/10.1177/147323000203000212
https://repository.urosario.edu.co/handle/10336/22385

Palabra clave:

Celecoxib
Cyclooxygenase 2 inhibitor
Diclofenac
Nonsteroid antiinflammatory agent
Celecoxib
Diclofenac
Nonsteroid antiinflammatory agent
Prostaglandin synthase inhibitor
Pyrazole derivative
Sulfonamide
Adult
Article
Clinical trial
Controlled clinical trial
Controlled study
Double blind procedure
Drug efficacy
Drug safety
Drug withdrawal
Dysphonia
Female
Fever
Gastrointestinal disease
Headache
Human
Incidence
Major clinical study
Male
Multicenter study
Nose congestion
Patient satisfaction
Pharyngitis
Quality of life
Randomized controlled trial
Sinusitis
Sore throat
South and central america
Swallowing
Symptom
Vertigo
Visual analog scale
Adolescent
Aged
Cohort analysis
Comparative study
Middle aged
Pain assessment
Pathophysiology
Treatment outcome
Virus infection
Adolescent
Adult
Aged
Cohort studies
Cyclooxygenase inhibitors
Diclofenac
Double-blind method
Female
Humans
Male
Middle aged
Pain measurement
Pharyngitis
Pyrazoles
Quality of life
Sulfonamides
Treatment outcome
Virus diseases
Celecoxib
Cyclooxygenase (cox)-2 specific inhibitors
Symptomatic treatment
Throat pain on swallowing
Viral pharyngitis
non-steroidal
Anti-inflammatory agents

Rights

License

Abierto (Texto Completo)